FORT LAUDERDALE, Fla. and NEW YORK , Nov. 15, 2024 /PRNewswire/ -- NavaDerm Partners, LLC ("NavaDerm" or the "Company"), a dermatology platform and portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), announced the exit of Dermatology and Surgery Associates ("DSA") to Schweiger Dermatology Group ("SDG").
DSA was part of the NavaDerm platform formed in 2018. Vera Abramova , Chief Financial Officer of NavaDerm Partners, LLC said, "We are pleased to announce this is the third practice sold to SDG in the past year. Our remaining flagship practices - Laser & Skin Surgery of New York with locations at 34 th Street (NYC) and Southampton and our growing Spring Street practice with NYC locations in SoHo and Uptown, continue to benefit from the tailwinds in cosmetic dermatology.
" Kevin Schirf , Chief Business Development Officer of SDG said, "Our group continues to scale its footprint in the Northeast, and we are excited about our expansion in the Bronx . It has been a pleasure working with NavaDerm and BelHealth throughout the acquisition process." Brown Gibbons Lang & Company served as the financial advisor and Moomjian, Waite & Coleman, LLP served as legal counsel to NavaDerm.
About BelHealth Investment Partners BelHealth Investment Partners, based in Fort Lauderdale, Florida , is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management, and entrepreneurial experience. BelHealth.
